Viatris Inc. (vtrs)
VTRS Estimates
Public analyst price targets and consensus snapshot for Viatris Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $17.12 |
| Analyst mean target | $18.78 |
| Analyst high target | $23.00 |
| Analyst low target | $13.00 |
| Upside vs mean target | 9.7% |
| Consensus recommendation | Buy |
| Number of analysts | 9 |
| Forward P/E | 6.40 |
Start Free — open VTRS in Vest Terminal
Access live data, filings, ownership, and analysis for Viatris Inc..
Viatris Inc. FAQ
What does Viatris Inc. (VTRS) do?
Viatris Inc., together with its subsidiaries, operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East. It operates in four segments: Developed Markets, Greater Ch…
What is VTRS's P/E ratio?
Viatris Inc. has a trailing P/E of N/A× based on publicly available market data.
Does VTRS pay a dividend?
Indicated dividend yield: 2.8%. Confirm ex-dates and payout history in Vest Terminal.
What sector is VTRS in?
Viatris Inc. is classified in Healthcare (Drug Manufacturers - Specialty & Generic) on NMS.
What is VTRS's market capitalization?
Approximate market cap: $19.66B.
What are the main risks for VTRS?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of VTRS?
Potential positives include gross margin of 40.3% supports competitive unit economics, positive free cash flow ($2.68b).
Where can I get analyst estimates for VTRS?
Public analyst price targets and consensus for Viatris Inc. are on the free /stocks/vtrs/estimates page. Deeper estimate history and models are available in Vest Terminal.